These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20739079

  • 1. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
    Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S.
    J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079
    [Abstract] [Full Text] [Related]

  • 2. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.
    Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S.
    Hepatology; 2006 Oct; 44(4):857-64. PubMed ID: 17006922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL.
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A.
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.
    Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S.
    PLoS One; 2012 Jan; 7(11):e48804. PubMed ID: 23144979
    [Abstract] [Full Text] [Related]

  • 9. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C, Opazo S, Murga MJ, Martínez-Castro P.
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [Abstract] [Full Text] [Related]

  • 10. Serum ferritin and transferrin saturation levels in β⁰ and β(+) thalassemia patients.
    Estevão IF, Peitl Junior P, Bonini-Domingos CR.
    Genet Mol Res; 2011 Apr 12; 10(2):632-9. PubMed ID: 21491373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N, National Hemochromatosis Transplant Registry.
    Gastroenterology; 2005 Aug 12; 129(2):494-503. PubMed ID: 16083706
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S.
    Scand J Gastroenterol; 2009 Aug 12; 44(3):366-74. PubMed ID: 19016382
    [Abstract] [Full Text] [Related]

  • 16. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
    Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, Fracanzani AL, Lattuada E, Zappa MA, Roviaro G, Marchesini G, Day CP, Fargion S.
    Gut; 2010 Feb 12; 59(2):267-73. PubMed ID: 20176643
    [Abstract] [Full Text] [Related]

  • 17. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep 12; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 18. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.
    Manco M, Alisi A, Real JF, Equitani F, DeVito R, Valenti L, Nobili V.
    J Hepatol; 2011 Sep 12; 55(3):647-653. PubMed ID: 21168460
    [Abstract] [Full Text] [Related]

  • 19. Dissecting the evolutionary genetics of iron overload in non-alcoholic fatty liver disease.
    Stickel F, Hampe J.
    J Hepatol; 2010 Nov 12; 53(5):793-4. PubMed ID: 20739088
    [No Abstract] [Full Text] [Related]

  • 20. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
    Raszeja-Wyszomirska J, Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J.
    World J Gastroenterol; 2010 May 28; 16(20):2531-6. PubMed ID: 20503453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.